Delivery Order SPE2DB20D3303-SPE2DB25FA3HT
- Not listed
- The Defense Logistics Agency awarded a $25,734.37 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with completion scheduled for September 4, 2025. This contract utilizes a firm fixed price structure and carries no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $10,100.87 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Humulin R 500 unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a $11,557.43 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Humulin R 500 Unit/mL KwikPen insulin pens (3 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $18,586.11 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $21,169.40 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's headquarters in Conshohocken, Pennsylvania. The award represents a single delivery of this insulin pharmaceutical product to support federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $12,000.90. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,220.03 delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This firm fixed-price, non-set-aside contract is scheduled for completion by July 17, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a critical pharmaceutical supply for military and federal healthcare systems...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $3,097.52. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $5,107.85 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed price delivery order with no set-aside designation, to be completed by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement fulfilling military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $4,646.28. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a pharmaceutical distributor,...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3HTDelivery Order
The Defense Logistics Agency awarded a $5,420.66 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was not set aside for small business or other designees and represents a competitively awarded transaction under the company's existing contract vehicle with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill federal medical procurement needs across multiple therapeutic domains, including insulin and other diabetes management medications essential for military medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/5/25 |